Literature DB >> 16575740

Oropharyngeal candidiasis: a new treatment option.

Stephen A Klotz1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16575740     DOI: 10.1086/501465

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

1.  Posaconazole (Noxafil): a new triazole antifungal agent.

Authors:  Nickie D Greer
Journal:  Proc (Bayl Univ Med Cent)       Date:  2007-04

Review 2.  Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.

Authors:  Elizabeth D Pienaar; Taryn Young; Haly Holmes
Journal:  Cochrane Database Syst Rev       Date:  2010-11-10

3.  Management of oropharyngeal candidiasis with localized oral miconazole therapy: efficacy, safety, and patient acceptability.

Authors:  Curtis D Collins; Sarah Cookinham; Jeannina Smith
Journal:  Patient Prefer Adherence       Date:  2011-07-19       Impact factor: 2.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.